3, 5-Diiodothyronine: Biological Actions and Therapeutic Perspectives

E-ISSN： 1875-6115|6|3|255-265

ISSN： 1871-5222

Source： Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol.6, Iss.3, 2006-06, pp. : 255-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bladder Cancer Stem Cells: Biological and Therapeutic Perspectives

Current Stem Cell Research & Therapy, Vol. 9, Iss. 2, 2014-03 ,pp. : 89-101

Bentham Science Publishers

Access to resources Recommend Favorite

Bladder Cancer Stem Cells: Biological and Therapeutic Perspectives

Current Stem Cell Research & Therapy, Vol. 9, Iss. 2, 2014-01 ,pp. : 89-101

Bentham Science Publishers

Access to resources Recommend Favorite

Mesenchymal Stem Cells in Renal Ischemia-Reperfusion Injury: Biological and Therapeutic Perspectives

Current Stem Cell Research & Therapy, Vol. 12, Iss. 3, 2017-02 ,pp. : 183-187

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Aspects and Therapeutic Perspectives of Relaxin

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 5, 2005-10 ,pp. : 403-410

Bentham Science Publishers

Access to resources Recommend Favorite

The Possible Therapeutic Actions of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists,PPAR&ggr; Agonists,3-Hydroxy-3- Methylglutaryl Coenzyme A (HMG-CoA)Reductase Inhibitors,Angiotensin Converting Enzyme (ACE)Inhibitors and Calcium (Ca)-Antagonists on Vascular Endothelial Cells

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 4, Iss. 1, 2004-03 ,pp. : 35-52

Bentham Science Publishers

Access to resources Recommend Favorite